Table 4.
Predictors of decisional regret at 12-months.
Predictors | Beta coefficients | 95% CI | P-value |
---|---|---|---|
Age | 0.58 | −0.17-1.32 | .12 |
Male vs. female | 2.37 | −15.63-20.37 | .79 |
White vs. non-White | 7.04 | −26.66-40.74 | .67 |
Non-Hispanic vs. Hispanic | −19.81 | −52.71-13.08 | .23 |
College graduate/more vs. some college/less | −17.13 | −50.26-16.00 | .30 |
Relapsed vs. did not relapse | 3.75 | −13.58-21.08 | .66 |
Stage IIIB vs. stage (IIIC, IIID, IV) | −6.16 | −23.65-11.33 | .48 |
CLND vs. no CLND | −19.82 | −39.47-0.17 | .05 |
irAEs | −5.45 | −33.50-22.60 | .69 |
Colitis | −17.14 | −63.61-29.33 | .46 |
Hypothyroid | 1.02 | −32.79-34.83 | .95 |
Vitligo | −27.5 | −73.19-18.19 | .23 |
*Tested using univariate linear regression.
Abbreviations: CLND, complete lymph node dissection; irAE; immune-related adverse event.